z-logo
open-access-imgOpen Access
Analysis and Characterization of Antiviral Drug–Resistant Cytomegalovirus Isolates from Solid Organ Transplant Recipients
Author(s) -
Nell S. Lurain,
Sangeeta Bhorade,
Kenneth Pursell,
Robin K. Avery,
Vijay Yeldandi,
Carlos M. Isada,
Emmanuel S. Robert,
Debra Kohn,
Max Q. Arens,
Edward R. Garrity,
Alan Taege,
Martin G. Mullen,
Kathleen Todd,
James W. Bremer,
Belinda YenLieberman
Publication year - 2002
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/342844
Subject(s) - drug resistance , cytomegalovirus , biology , population , virology , organ transplantation , immunology , drug , polymerase chain reaction , transplantation , virus , medicine , viral disease , herpesviridae , gene , microbiology and biotechnology , pharmacology , genetics , environmental health
The development of cytomegalovirus (CMV) disease and subsequent emergence of drug-resistant strains was examined in a large group of solid organ transplant recipients; drug-resistant CMV was detected in a total of 30 transplant recipients (20 lung, 5 kidney, 4 heart, and 1 liver). Drug resistance was confirmed both phenotypically and genotypically. The sequences of drug-resistant CMV strains from the same patient differed from drug-susceptible baseline sequences only at single sites previously confirmed to confer drug resistance. At least 1 isolate from each patient had a mutation in the UL97 phosphotransferase coding sequence. Mutations in the DNA polymerase gene were found in 6 of 38 sequenced strains. Lung transplant recipients had the highest incidence of drug-resistant virus: of the 30 patients, 28 were CMV-seronegative transplant recipients of CMV-seropositive organs, which strongly supports the premise that drug resistance is most prevalent in that transplant population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom